Month: July 2020

Disconnected. This seems to be the best way to describe the current economic environment. Amid high levels of unemployment and tanking earnings, stocks aren’t just hanging in there, they’re charging forward. As a result, traditional metrics might not be enough to display the big picture. In this case, other tools are needed.TipRanks offers one such tool that can make finding compelling plays feel less like a fool’s errand. The Smart Score feature utilizes the comprehensive market data collected by the platform, collating it according to 8 key metrics often used to gauge the trajectory of a given name. After all …read more […]

If you are looking for the best ideas for your portfolio you may want to consider some of Mott Capital’s top stock picks. Mott Capital, an investment management firm, is bullish on Skyworks Solutions Inc. (NASDAQ:SWKS) stock. In its Q4 2019 investor letter – you can download a copy here – the firm discussed its […] …read more […]

The administrator of collapsed German payments firm Wirecard said on Tuesday that more than 100 investors have expressed interest in buying the company’s core business and its holdings. “The aim is to find timely investor solutions in the interest of creditors, employees and customers,” Michael Jaffe said in a statement after a meeting of creditors. Jaffe added that the sale of Wirecard North America’s assets was most advanced, with investment bank Moelis & Company already mandated to support such a sale. …read more […]

If you are looking for the best ideas for your portfolio you may want to consider some of Mott Capital’s top stock picks. Mott Capital, an investment management firm, is bullish on Acadia Pharmaceuticals Inc (NASDAQ:ACAD) stock. In its Q4 2019 investor letter – you can download a copy here – the firm discussed its […] …read more […]

Are you looking to invest in Dogecoin but don’t know where to start? If so, you have come to the right place. Cryptocurrency assets come with a lot of risk. However, it’s also growing in popularity amongst investors.
The crypto market is crowding up quickly. But, Dogecoin has turned a fun joke into an actual investment opportunity. Take a glance at its thriving community and you will understand why.

Why Should You Invest in Dogecoin?
Dogecoin investing is community-based and that’s exactly where its potential lies. For example, disaster struck just weeks after its original release in 2013. On December 25th, a hacker …read more […]

Yahoo Finance’s Brian Sozzi, Alexis Christoforous, and Ines Ferre break down the market action for Tesla. …read more […]

(Bloomberg) — Novavax Inc., one of the front-runners in the race to develop a Covid-19 vaccine, will receive $1.6 billion from the U.S. government, the biggest contribution yet from the Operation Warp Speed program.The funds will allow the company to conduct advanced human studies and establish manufacturing to deliver 100 million doses as soon as late 2020, Gaithersburg, Maryland-based Novavax said in a statement.Shares of Novavax rose as much as 41%, the highest since September 2016, in Tuesday trading.Novavax is among companies striving to develop an inoculation against the novel coronavirus that’s spreading quickly in countries including the U.S., India …read more […]

(Bloomberg) — Delta Air Lines Inc. and United Airlines Holdings Inc. are among major airlines that may tap a federal loan program as the industry copes with the coronavirus pandemic damages, the Treasury Department announced Tuesday.Southwest Airlines Co. and JetBlue Airways Corp. have also told the agency that they may need a share of the $25 billion pandemic relief loan program that Congress allotted for the industry. Last week, the Treasury Department said that American Airlines Group Inc., Frontier Airlines, Hawaiian Airlines, SkyWest, and Spirit Airlines also indicated that they may take the federal aid, with American confirming it would …read more […]

Corvus Pharmaceuticals Inc. (CRVS) shares shot up 115% on Tuesday after the clinical-stage biopharma company said that it has initiated a Phase 1 study to investigate a novel immunotherapy approach for patients with COVID-19.The stock surged to $5.85 in early morning trading. Novavax reported that the first cohort of 5 patients enrolled in the study was treated at Temple University Hospital in Philadelphia. The initiation follows the U.S. Food and Drug Administration’s (FDA) review and approval of the company’s investigational new drug (IND) application for the COVID-19 study. The trial will evaluate anti-viral antibody response in up to 30 COVID-19 …read more […]

(Bloomberg) — Sunrun Inc., America’s biggest rooftop-solar company, is set to become a behemoth through a $1.46 billion takeover of its rival Vivint Solar Inc. Shares of both companies surged.The agreement announced late Monday is one of the industry’s biggest. It comes after Tesla Inc.’s 2016 purchase of debt-plagued SolarCity Corp. and the failed 2015 acquisition of Vivint by SunEdison Inc., the clean-energy giant that went bankrupt soon after.The second major U.S. energy deal in as many days — following Berkshire Hathaway Inc.’s $4 billion purchase of Dominion Energy Inc. assets — also threatens to further weaken Tesla’s grip on …read more […]

There’s an interesting subtext to pharmaceutical companies’ battle against COVID-19. Taming the “invisible enemy” is undoubtedly the main objective, but the race for a vaccine or treatment has also created a David vs. Goliath narrative between the companies chasing solutions.July 1 provided a good example of this subtle duel.Pharma giant Pfizer and its partner, BioNTech, presented the first set of positive data from a Phase 1/2 study of their experimental coronavirus vaccine.All 24 participants who received two doses (of either 10 or 30 micrograms) of its BNT162b1 candidate produced neutralizing antibodiesseven days after the second dose.As a result, shares of …read more […]

(Bloomberg) — Bayer AG’s plan for moving on from its Roundup legal woes hit a snag barely two weeks after it announced a nearly $11 billion settlement of claims the popular weedkiller causes cancer when a judge expressed skepticism about its proposed treatment of future claims.U.S. District Judge Vince Chhabria called the plan to create a class action for future litigants problematic in a court filing Monday and said he was “tentatively inclined” to reject it. He set a July 24 hearing date. Shares of Bayer, which inherited the weedkiller through its purchase of Monsanto, fell as much as 7.1% …read more […]